Insulin pump initiation and education for children and adolescents – a qualitative study of current practice in New Zealand

  • Yasmin H. AbdulAziz
  • Hesham S. Al-SallamiEmail author
  • Esko Wiltshire
  • Jenny Rayns
  • Jinny Willis
  • Joanna McClintock
  • Natalie Medlicott
  • Benjamin J. Wheeler
  • the Paediatric Society of New Zealand Diabetes Clinical Network
Research Article



Worldwide, the use of insulin pumps for the management of type 1 diabetes is increasing. There are no national or international published guidelines and few guidance recommendations detailing the education and training required to commence insulin pump therapy. The aim of this study is to describe current clinical practice regarding initiation of insulin pump therapy in children and adolescents with type 1 diabetes in New Zealand.


Pediatric diabetes nurse specialists from selected New Zealand hospitals (n = 16) were identified and invited to participate in this qualitative study. For those consenting, structured interviews were conducted. The questions covered basic hospital demographics and various aspects of insulin pump initiation including pump start planning, education, and aspects of follow-up and after-care.


The response rate was 100% (16 out of 16 hospitals). Diabetes clinics interviewed varied in size from 50 to 450 pediatric patients and frequency of insulin pump use from 11% - 46%. Clinical practice differed between clinics. Important differences related to: use of continuous glucose monitoring (12/16); and differing views on immediate vs. delayed use of pump advanced features. Location of pump starts also varied, with both in-patient (2/16) and out-patient (14/16) approaches seen. The motivations and beliefs relating to these various pump start approaches also varied.


Differences seen between hospitals reflected team preference, and possibly a lack of consensus/guidance from the medical literature. Lessons may be learnt and further rationalisation and improvement in education remains possible by combining and adopting strengths from different hospitals.


Type 1 diabetes Pediatric Education Insulin pump Continuous subcutaneous insulin infusion 



The authors wish to thank all the participants and the Paediatric Society of New Zealand Diabetes Clinical Network for their time and assistance with this study. The authors would also like to thank the School of Pharmacy, University of Otago, Dunedin, New Zealand for the funding given to carry out this project.


  1. 1.
    The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N Engl J Med. 1993;329(14):977–86.CrossRefGoogle Scholar
  2. 2.
    Danne T, Bangstad H-J, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B, et al. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(S20):115–34.CrossRefGoogle Scholar
  3. 3.
    Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al. Care of children and adolescents with type 1 diabetes a statement of the American Diabetes Association. Diabetes Care. 2005;28(1):186–212.CrossRefGoogle Scholar
  4. 4.
    Craig, ME TS, Donaghue KC, Cheung NW, Cameron FJ, Conn J, Jenkins AJ, Silink M, for the Australian Type 1 Diabetes Guidelines Expert Advisory Group. National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Canberra, Australia: Australian Government Department of Health and Ageing; 2011.Google Scholar
  5. 5.
    Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009;10(1):52–8.CrossRefGoogle Scholar
  6. 6.
    Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010(1):CD005103.Google Scholar
  7. 7.
    Cooper MN, O'Connell SM, Davis EA, Jones TW. A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes. Diabetologia. 2013;56(10):2164–70.CrossRefGoogle Scholar
  8. 8.
    Wheeler BJ, Heels K, Donaghue KC, Reith DM, Ambler GR. Insulin pump–associated adverse events in children and adolescents—a prospective study. Diabetes Technol Ther. 2014;16(9):558–62.CrossRefGoogle Scholar
  9. 9.
    Ross P, Milburn J, Reith D, Wiltshire E, Wheeler B. Clinical review: insulin pump-associated adverse events in adults and children. Acta Diabetol. 2015;52(6):1017–24.CrossRefGoogle Scholar
  10. 10.
    Wheeler BJ, Donaghue KC, Heels K, Ambler GR. Family perceptions of insulin pump adverse events in children and adolescents. Diabetes Technol Ther. 2014;16(4):204–7.CrossRefGoogle Scholar
  11. 11.
    Bode BW, Kaufman FR, Vint N. An expert opinion on advanced insulin pump use in youth with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):145–54.CrossRefGoogle Scholar
  12. 12.
    Scheiner G, Sobel RJ, Smith DE, Pick AJ, Kruger D, King J, et al. Insulin pump therapy guidelines for successful outcomes. Diabetes Educator. 2009;35(2 suppl):29S–41S.CrossRefGoogle Scholar
  13. 13.
    Swift PGF. Diabetes education in children and adolescents. Pediatr Diabetes. 2009;10:51–7.CrossRefGoogle Scholar
  14. 14.
    PHARMAC. Funding of New Zealand Medical and Scientific Insulin pump and consumables approved 2012 [cited 2016 02 June]. Available from: Accessed 02 June 2016.
  15. 15.
    Selvakumar D, Al-Sallami HS, de Bock M, Ambler GR, Benitez-Aguirre P, Wiltshire E, et al. Insulin regimens for newly diagnosed children with type 1 diabetes mellitus in Australia and New Zealand: a survey of current practice. J Paediatr Child Health. 2017;53(12):1208–14.CrossRefGoogle Scholar
  16. 16.
    Phelan H, Clapin H, Bruns L, Cameron FJ, Cotterill AM, Couper JJ, et al. The Australasian diabetes data network: first national audit of children and adolescents with type 1 diabetes. Med J Aust. 2017;206(3):121–5.CrossRefGoogle Scholar
  17. 17.
    Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 2003;111(5):933–8.CrossRefGoogle Scholar
  18. 18.
    Sussman A, Taylor EJ, Patel M, Ward J, Alva S, Lawrence A, et al. Performance of a glucose meter with a built-in automated bolus calculator versus manual bolus calculation in insulin-using subjects. J Diabetes Sci Technol. 2012;6(2):339–44.CrossRefGoogle Scholar
  19. 19.
    Grunberger G, Abelseth JM, Bailey TS, Bode BW, Handelsman Y, Hellman R, et al. Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2014;20(5):463–89.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Yasmin H. AbdulAziz
    • 1
  • Hesham S. Al-Sallami
    • 1
    Email author
  • Esko Wiltshire
    • 2
  • Jenny Rayns
    • 3
  • Jinny Willis
    • 4
  • Joanna McClintock
    • 5
  • Natalie Medlicott
    • 1
  • Benjamin J. Wheeler
    • 3
    • 6
  • the Paediatric Society of New Zealand Diabetes Clinical Network
  1. 1.School of PharmacyUniversity of OtagoDunedinNew Zealand
  2. 2.Department of Paediatrics and Child HealthUniversity of Otago WellingtonWellingtonNew Zealand
  3. 3.Paediatric EndocrinologySouthern District Health BoardDunedinNew Zealand
  4. 4.Don Beaven Medical Research HospitalChristchurchNew Zealand
  5. 5.Paediatric DiabetesWaikato District Health BoardHamiltonNew Zealand
  6. 6.Women’s and Children’s HealthUniversity of OtagoDunedinNew Zealand

Personalised recommendations